I have been reading about a variant of fisetin molecule, specifically made to interact with mitochondria:
New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells
https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c01664
It seems like a synthetic compound different from fisetin, did anyone has any take on this?
Fabio